Skip to main content
Top
Published in: Israel Journal of Health Policy Research 1/2018

Open Access 01-12-2018 | Commentary

TB Anywhere is TB Everywhere

Author: Jonathan M. Wortham

Published in: Israel Journal of Health Policy Research | Issue 1/2018

Login to get access

Abstract

To control and prevent outbreaks, public health programs in all countries, regardless of tuberculosis (TB) incidence, must maintain the capacity to perform core control and prevention activities. These include diagnosing and treating cases, contact investigations, and infection prevention and control activities. Congregate settings and healthcare facilities demand special attention, because of the potential for outbreaks associated with infectious cases in these settings. Since almost one-fourth of the world population is thought to be infected with Mycobacterium tuberculosis, enhanced efforts to diagnose and treat latent TB infection are needed to prevent future cases and accelerate progress towards TB elimination.
Literature
2.
go back to reference World Health Organization (WHO). Global tuberculosis report 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NCSA 3.0 IGO. World Health Organization (WHO). Global tuberculosis report 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NCSA 3.0 IGO.
3.
go back to reference Centers for Disease Control and Prevention. Essential components of a tuberculosis prevention and control program. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep. 1995;44(RR-11):1–16. Centers for Disease Control and Prevention. Essential components of a tuberculosis prevention and control program. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep. 1995;44(RR-11):1–16.
4.
go back to reference Mindra G, Wortham JM, Haddad MB, et al. Tuberculosis outbreaks in the United States, 2009-2015. Pub Health Rep. 2017;132(2):157–63.CrossRef Mindra G, Wortham JM, Haddad MB, et al. Tuberculosis outbreaks in the United States, 2009-2015. Pub Health Rep. 2017;132(2):157–63.CrossRef
5.
go back to reference Jensen PA, Lambert LA, Iademarco MF, et. al. Guidelines for preventing the transmission of mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005;54(RR-17):1–141.PubMed Jensen PA, Lambert LA, Iademarco MF, et. al. Guidelines for preventing the transmission of mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005;54(RR-17):1–141.PubMed
6.
go back to reference Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. MMWR Recomm Rep. 2006;55(RR-9):1–44. Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. MMWR Recomm Rep. 2006;55(RR-9):1–44.
7.
go back to reference Centers for Disease Control and Prevention. Prevention and control of tuberculosis among homeless persons. MMWR 1992;41(RR-5):13–23. Centers for Disease Control and Prevention. Prevention and control of tuberculosis among homeless persons. MMWR 1992;41(RR-5):13–23.
9.
go back to reference Tsang CA, Langer AJ, Navin TR, Armstrong LR. Tuberculosis Among Foreign-Born Persons Diagnosed ≥10 Years After Arrival in the United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2017;66(11):295–8.CrossRefPubMedPubMedCentral Tsang CA, Langer AJ, Navin TR, Armstrong LR. Tuberculosis Among Foreign-Born Persons Diagnosed ≥10 Years After Arrival in the United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2017;66(11):295–8.CrossRefPubMedPubMedCentral
10.
go back to reference Centers for Disease Control and Prevention (CDC). Recommendations for use of an isoniazidrifapentine regimen with direct observation to treat latent mycobacterium tuberculosis infection. MMWR Morb Mortal Wkly Rep. 2011;60(48):1650–3. Centers for Disease Control and Prevention (CDC). Recommendations for use of an isoniazidrifapentine regimen with direct observation to treat latent mycobacterium tuberculosis infection. MMWR Morb Mortal Wkly Rep. 2011;60(48):1650–3.
11.
go back to reference Kawati LC, Feltner C, Halpern M, et. al. Primary care screening and treatment for latent tuberculosis infection in adults: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016;316(9):970–83. Kawati LC, Feltner C, Halpern M, et. al. Primary care screening and treatment for latent tuberculosis infection in adults: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016;316(9):970–83.
Metadata
Title
TB Anywhere is TB Everywhere
Author
Jonathan M. Wortham
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Israel Journal of Health Policy Research / Issue 1/2018
Electronic ISSN: 2045-4015
DOI
https://doi.org/10.1186/s13584-018-0233-0

Other articles of this Issue 1/2018

Israel Journal of Health Policy Research 1/2018 Go to the issue